Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0M0TS
|
|||
Former ID |
DNC013235
|
|||
Drug Name |
(2S)-aminobutyryl-L-proline (R)-sec-butylamide
|
|||
Synonyms |
CHEMBL376183; (2S)-aminobutyryl-L-proline (R)-sec-butylamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H25N3O2
|
|||
Canonical SMILES |
CCC(C)NC(=O)C1CCCN1C(=O)C(CC)N
|
|||
InChI |
1S/C13H25N3O2/c1-4-9(3)15-12(17)11-7-6-8-16(11)13(18)10(14)5-2/h9-11H,4-8,14H2,1-3H3,(H,15,17)/t9-,10+,11+/m1/s1
|
|||
InChIKey |
VEBCSYAWQCGSMV-VWYCJHECSA-N
|
|||
CAS Number |
CAS 885007-99-8
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Tripeptidyl-peptidase II (TPP2) | Target Info | Inhibitor | [1] |
Reactome | Antigen processing: Ubiquitination & Proteasome degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach ... J Med Chem. 2005 Nov 17;48(23):7333-42. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.